Gender Differences in Presentation, Management, and In-Hospital Outcomes for Patients with AMI in a Lower-Middle Income Country: Evidence from Egypt by Butala, Neel M. et al.
Gender Differences in Presentation, Management, and
In-Hospital Outcomes for Patients with AMI in a Lower-
Middle Income Country: Evidence from Egypt
Neel M. Butala
1*, Mayur M. Desai
2,3,4, Erika L. Linnander
2, Y. Rex Wong
2, Daoud G. Mikhail
3, Lesli S. Ott
3,
John A. Spertus
5,6, Elizabeth H. Bradley





10, Mohamed El Baz
10, A. H. Allam
10, Harlan M. Krumholz
1,2,3,4
1Yale School of Medicine, New Haven, Connecticut, United States of America, 2Yale School of Public Health, New Haven, Connecticut, United States of America, 3Center
for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven, Connecticut, United States of America, 4The Robert Wood Johnson Clinical Scholars
Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America, 5Mid America Heart Institute, Kansas
City, Missouri, United States of America, 6Kansas City School of Medicine, University of Missouri, Kansas City, Missouri, United States of America, 7Alexandria University,
Alexandria, Egypt, 8Cairo University, Cairo, Egypt, 9Medinat Nasr Hospital, Cairo, Egypt, 10Al-Azhar University, Cairo, Egypt
Abstract
Background: Many studies in high-income countries have investigated gender differences in the care and outcomes of
patients hospitalized with acute myocardial infarction (AMI). However, little evidence exists on gender differences among
patients with AMI in lower-middle-income countries, where the proportion deaths stemming from cardiovascular disease is
projected to increase dramatically. This study examines gender differences in patients in the lower-middle-income country
of Egypt to determine if female patients with AMI have a different presentation, management, or outcome compared with
men.
Methods and Findings: Using registry data collected over 18 months from 5 Egyptian hospitals, we considered 1204
patients (253 females, 951 males) with a confirmed diagnosis of AMI. We examined gender differences in initial presentation,
clinical management, and in-hospital outcomes using t-tests and x
2 tests. Additionally, we explored gender differences in
in-hospital death using multivariate logistic regression to adjust for age and other differences in initial presentation. We
found that women were older than men, had higher BMI, and were more likely to have hypertension, diabetes mellitus,
dyslipidemia, heart failure, and atrial fibrillation. Women were less likely to receive aspirin upon admission (p,0.01) or
aspirin or statins at discharge (p=0.001 and p,0.05, respectively), although the magnitude of these differences was small.
While unadjusted in-hospital mortality was significantly higher for women (OR: 2.10; 95% CI: 1.54 to 2.87), this difference did
not persist in the fully adjusted model (OR: 1.18; 95% CI: 0.55 to 2.55).
Conclusions: We found that female patients had a different profile than men at the time of presentation. Clinical
management of men and women with AMI was similar, though there are small but significant differences in some areas.
These gender differences did not translate into differences in in-hospital outcome, but highlight differences in quality of
care and represent important opportunities for improvement.
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Introduction
Many studies in high-income countries have investigated gender
differences in the care and outcomes of patients hospitalized with
an acute myocardial infarction (AMI). The studies have indicated
gender differences in the initial clinical presentation and the
patterns of care, such as provision of evidence-based therapies
[1,2]. Evidence supporting gender differences in in-hospital
mortality is mixed, though studies have shown that younger
women with AMI compared with similarly aged men face a higher
risk of dying in hospital [3].
In Egypt, cardiovascular disease has emerged the leading cause
of death, and women are affected in large numbers [4]; however,
little is known about the association of patient gender with patient
care and outcomes in Egypt. Raising the specter of similar
patterns within the Middle East, a regional study from six Arabian
Peninsula countries found that women were less likely to re-
ceive certain treatments and had worse risk-adjusted in-hospital
outcomes compared with men [5]. Nevertheless, these countries
are distinctly different from Egypt, which has a much larger
population, smaller percentage of expatriates, and a lower per
capita income. Egypt is a lower-middle income country by World
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cardiovascular disease is projected to increase dramatically in such
countries with limited socioeconomic status [7].
Accordingly, we sought to examine gender differences in the
presentation, management, and in-hospital outcomes of patients
with AMI using registry data from 5 Egyptian hospitals. Our
purpose was to determine if female patients with AMI have a
different clinical presentation, treatment patterns, or outcome
compared with men. Illuminating any disparities can help identify
targets for quality improvement intervention and reveal particular
patterns of care that may be prevalent in Egypt.
Methods
Ethics Statement
The Yale School of Medicine Human Investigations Committee
(HIC) has determined that this study is not considered to be
Human Subjects Research and is thus exempt from HIC review
because the pre-existing data used in this study did not contain
identifiable private information and were not collected by
investigators through intervention or interaction with individuals.
Written consent was not obtained because the data were analyzed
anonymously.
The data in this study were collected as a part of a broader
health system strengthening initiative. These data were not
specifically collected for the current research project, and there
is a documented mechanism in place that prevents the inves-
tigators from obtaining access to identifiers.
Setting
This study uses data from an ongoing registry for patients
with AMI in 5 Egyptian hospitals in Cairo and Alexandria,
including 2 university-affiliated public hospitals, 1 public
hospital affiliated with the Ministry of Health, 1 private
hospital, and 1 university-affiliated hospital that has both
public and private wings. These hospitals were purposefully
selected to represent a diverse set of healthcare facilities in
Egypt. The healthcare system in Egypt is highly pluralistic,
with government sector providers funded solely by the
Egyptian government, public sector providers funded by both
the Egyptian government and other affiliated sources, and
private sector providers [8]. Individuals with AMI who present
to public or government hospitals generally do not have to pay
out of pocket for services. Nearly all MOH tertiary care
facilities, university hospitals, army and police hospitals, and
large private hospitals (.100 beds) have CCUs. In these
facilities, patients with AMI are generally admitted to the
CCU, though specific criteria for admission to CCUs vary
s i g n i f i c a n t l yb yh o s p i t a l .
Participants and Study Design
Across the 5 hospitals in this study, a total of 1438 consecutive
patients were admitted to the cardiac care unit (CCU) with
suspected AMI over a period of 18 months between July 2009 and
December 2010. Patients with a confirmed diagnosis of AMI,
defined as a clinical suspicion of AMI with unequivocal EKG
findings (ST-elevated myocardial infarction (STEMI) or STEMI-
equivalent) or elevated serum levels of cardiac markers (troponin,
CK-MB, creatinine) were included in the study; resulting in a total
of 1204 patients meeting eligibility criteria.
Observations from the 238 patients who had incomplete dis-
charge were excluded from analysis of discharge practices and in-
hospital outcomes. These patients left the hospital for various
reasons, such as leaving to obtain insurance approval or collect
finances to make a payment for care. The percentage of patients
with incomplete discharge status was similar by gender (19.8% for
women vs. 20.0% for men). Observations from the 101 patients
who were deceased were excluded from analysis of discharge
practices.
Data Collection
Data on admission, cardiac status on first medical contact,
history and risk factors, medications, procedures, in-hospital
clinical events, laboratory results, and discharge were collected
during the hospitalization using a tool based on the American
College of Cardiology NCDR ACTION-GWTG registry [9]. The
NCDR ACTION-GWTG registry tool was modified through
rapid cycles of change to ensure that it was culturally and
logistically appropriate for Egypt, while allowing for comparisons
with the United States [10]. To insure complete data collection,
information pertaining to the index hospitalization was compiled
on a data collection form used throughout the hospital stay by
clinicians at each site. Information on past cardiac history, risk
factors, and events before the index hospital admission was self-
reported by patients to the clinicians completing the data
collection form under the supervision of principal investigators
in all sites.
Registry forms from the different hospital sites were collected
during weekly site visits by research assistants from the coor-
dinating center. The weekly site visits also served to share
strategies for optimizing data collection among the sites and solicit
feedback that could improve the process. Forms were screened for
completeness on-site before being sent to a central office for data
entry. Any registry forms received with unclear information were
examined by a cardiologist before being sent back to the hospital
sites for clarification, if necessary. Paper copies of all completed
registry forms were kept in the central office after data had been
entered for quality assurance. Monthly reports with site-specific
and registry-wide summary statistics (not stratified by gender) were
generated and circulated to each site in order to provide constant
feedback to sites about data quality and performance on key
indicators of healthcare quality.
Measures
Variables examined included cardiac risk factors, cardiac
history, cardiac status on admission, clinical management, and
in-hospital outcomes. Cardiac risk factors included age, body mass
index (BMI), smoking status, and diagnosis of hypertension,
dyslipidemia, and diabetes mellitus according to Acute Coronary
Syndromes Data Standards prior to arrival at first hospital [11].
Elements of prior cardiac history examined include heart failure,
myocardial infarction, percutaneous coronary intervention
(PCI), coronary artery bypass graft (CABG) surgery, and atrial
fibrillation. Elements of cardiac status examined on admission
included heart rate, blood pressure, and presence of STEMI on
EKG between first medical contact and 24 hours after arrival at
first hospital. Additionally we examined whether patients were
transferred from another hospital.
Clinical management variables examined include use of aspirin
in first 24 hours, anticoagulants (heparin, enoxaparin, or fonda-
parinux), GP IIb/IIIa inhibitor, utilization of echocardiogram,
angiography, or reperfusion therapy in clinically eligible patients,
fibrinolytic therapy in patients with STEMI, provision of smoking
cessation counseling for smokers, scheduling of follow-up appoint-
ments, and administration of aspirin, beta blockers, and statins at
discharge.
In-hospital outcomes that were prospectively collected included
reinfarction according to criteria outlined above, cardiogenic
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ing event, and in-hospital mortality. Many of these process and
outcomes indicators are aligned with a range of ‘‘core quality
measures’’ for AMI, as defined by the US Centers for Medicare &
Medicaid Services (CMS) [12], including administration of aspirin
at admission and discharge, smoking cessation counseling, and
prescribing of beta blockers and statins at discharge.
Statistical Analysis
The analysis was conducted in three steps. First, we examined
gender differences in initial presentation upon arrival at the
hospital. Specifically, we sought to determine whether male and
female AMI patients differed with respect to cardiac risk factors,
prior cardiac history, and cardiac status on admission; t-tests and
x2 tests were used for continuous and dichotomous variables,
respectively. Similarly, we used t-tests and x
2 tests to examine
differences in the clinical management and in-hospital outcomes
between men and women. We also explored gender differences in
in-hospital death using logistic regression modeling. Multivariable
analysis was performed to adjust the sex effect for age and other
differences in initial presentation; we fit the model using
sequential adjustment for age, smoking status, hypertension,
diabetes mellitus, prior CABG, prior heart failure, heart rate on
admission, systolic blood pressure on admission, heart failure on
admission, and ST-elevation. Our logistic regression modeling
used generalized estimating equation techniques to account for
the clustering of patients within hospitals [13]. All analyses were
conducted using STATA 11.0 IC (StataCorp, College Station,
TX).
Results
Our analysis included 1204 patients (253 females, 951 males).
Patient presenting characteristics
Women were significantly more likely to have risk factors
for cardiovascular disease (Table 1). Women on average were
older than men (p,0.001) and had a significantly higher BMI
(p,0.001). In addition, they were more likely to have hypertension
(69% vs. 47%; p,0.001), diabetes mellitus (58% vs. 40%;
p,0.001), and dyslipidemia (31% vs. 18%; p,0.001). Men,
however, were significantly more likely to be current or recent
smokers (65% vs. 8%; p,0.001).
Prior cardiac history also differed significantly by gender.
Women were more likely to have had prior heart failure (10% vs.
3%; p,0.001) and atrial fibrillation (4% vs. 1%; p,0.001), while
men were more likely to have undergone prior PCI (13% vs. 8%;
p,0.05). No significant difference in incidence of prior myocardial
infarction or prior CABG was found.
Additionally, cardiac status on admission revealed significant
gender differences. ST-elevated myocardial infarction was more
common in men (74% vs. 58%; p,0.001), while heart failure
upon admission was more common in women (21% vs. 14%;
p,0.05). No significant difference in heart rate, systolic blood
pressure, or transfer status was found.
Clinical Management
Gender differences in the management of AMI were generally
small though statistically significant for some processes of care
(Table 2). Among patients without contraindications, women
compared with men were slightly less likely to receive aspirin
within 24 hours of admission (97% vs. 99%; p,0.01), anticoag-
ulants during the hospital stay (95% vs. 98%; p,0.05),
angiography during hospital stay (22% vs. 28%; p,0.05), aspirin
at discharge (95% vs. 99%; p,0.01), or statins at discharge (92%
vs. 96%; p,0.05). Additionally, women were more likely to be
Table 1. Gender differences in initial presentation.
Variable Sample Men (% yes) Women (% yes) p-value from X
2
N 1204 951 253
Cardiac Risk Factors
Mean Age
a 1177 56.0(10.7) 61.0(11.3) ,0.001
Mean BMI
a 1113 28.5(4.4) 31.3(5.2) ,0.001
Smoker 1179 604(65) 21(8) ,0.001
Hypertension 1194 445(47) 173(69) ,0.001
Dyslipidemia 957 134(18) 64(31) ,0.001
Diabetes Mellitus 1194 378(40) 147(58) ,0.001
Prior Cardiac History
Prior MI 1185 167(18) 32(13) 0.061
Prior HF 1192 29(3) 26(10) ,0.001
Prior PCI 1188 118(13) 20(8) 0.042
Prior CABG 1186 31(3) 4(2) 0.149
Prior atrial fibrillation 1177 9(1) 11(4) ,0.001
Cardiac Status on Admission
STEMI 1182 691(74) 143(58) ,0.001
Mean Heart Rate
a 1170 86.1(21.9) 87.4(23.2) 0.441
Mean Systolic Blood Pressure
a 1154 130.6(27.7) 134.1(30.9) 0.091
Heart Failure on Admission 1182 134(14) 51(21) 0.015
Transfer patient 987 171(22) 35(18) 0.202
aMean (standard deviation) and p-values from t-test reported for continuous variables.
doi:10.1371/journal.pone.0025904.t001
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contrast, there were large gender differences in smoking cessation
counseling, with women being less likely to receive smoking
cessation counseling if they were smokers (73% vs. 92%; p,0.05).
No significant gender differences were found in administration of
GP IIb/IIIa inhibitors, use of echocardiography, reperfusion
strategy, hospital duration, or administration of beta blockers at
discharge.
In-hospital Complications
There were no significant gender differences in in-hospital
clinical events, such as reinfarction, cardiogenic shock, heart
failure, cerebrovascular accident, or suspected bleeding event
(Table 2).
In-hospital Mortality
The unadjusted in-hospital mortality rate for the entire sample
was 10.6%, with a gender-specific mortality rate of 8.9% for males
and 17.0% for females (p,0.01). Unadjusted logistic regression
analysis indicated that the odds of in-hospital mortality was
significantly higher for women compared with men (unadjusted
OR: 2.10; 95% CI: 1.54 to 2.87) (Table 3). This difference
persisted after adjustment for age (adjusted OR: 1.66; 95% CI:
1.14 to 2.42) but became non-significant after the addition of
cardiac risk factors, including smoking, hypertension, and diabetes
mellitus (adjusted OR: 1.26; 95% CI: 0.84 to 1.89). After
subsequent adjustment for cardiac history, such as prior heart
failure or prior CABG, the gender difference in in-hospital
mortality was further attenuated (adjusted OR: 1.15; 95% CI: 0.74
to 1.81). Additional adjustment for cardiac status on admission
had minimal effect on the point estimate for gender difference in
in-hospital mortality but substantially widened the confidence
interval (adjusted OR: 1.18; 95% CI: 0.55 to 2.55).
Discussion
Many studies in high-income countries have found gender
differences in the presentation, care and outcomes of patients
hospitalized with AMI [1–3]. This study is the first to investigate
gender differences in the presentation, care and outcomes of AMI
in Egypt, a country of lower-middle income status in the Middle
East. We found that female patients have a significantly different
clinical profile than men at the time of presentation. Additionally,
clinical management of men and women with AMI was very
similar, though there is indication that there are some areas where
the differences are substantial. Specifically, women had small but
significant deficiencies in the receipt of aspirin within the first
24 hours of presentation, anticoagulants or angiography during
Table 2. Gender differences in clinical management and in-hospital outcomes.




Aspirin in first 24 hours
a 1195 936(99) 243(97) 0.004
Anticoagulants 1167 900(98) 232(95) 0.017
GP IIb/IIIa inhibitor 1162 107(12) 18(7) 0.058
Diagnostics
Echocardiogram 1183 680(73) 188(76) 0.392
Angiography 1169 263(28) 53(22) 0.029
Reperfusion
Reperfusion therapy if candidate 628 519(97) 89(96) 0.507
Thrombolytics if STEMI 602 457(90) 83(90) 0.876
Discharge
Follow-up appointment scheduled 708 348(61) 101(72) 0.024
Smoking cessation counseling if smoker
a 444 399(92) 8(73) 0.021
Aspirin at dischargea 835 664(99) 156(95) 0.001
Beta blocker at discharge
a 818 591(89) 134(86) 0.232
Statins at discharge
a 839 650(96) 150(92) 0.025
Hospital stay duration (days)
b 813 5.6 (5.9) 5.8 (5.3) 0.682
In-Hospital Outcomes
Clinical events
Reinfarction 961 21(3) 10(5) 0.123
Cardiogenic shock 959 66(9) 26(13) 0.075
Heart failure 960 101(13) 31(15) 0.458
CVA 959 11(1) 0(0) 0.085
Major Bleed 945 32(4) 9(5) 0.859
Mortality 954 67(9) 34(17) 0.001
aRecognized by Centers for Medicare & Medicaid Services (CMS) as ‘‘Core Measures’’ for AMI for inpatient hospital quality.
bMean(standard deviation) and p-value from t-test reported for continuous variables.
doi:10.1371/journal.pone.0025904.t002
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substantially less likely to receive smoking cessation counseling
and more likely to be scheduled for a follow-up appointment.
However, these statistically significant gender differences in clinical
management did not translate into differences in most in-hospital
outcomes. While crude in-hospital mortality in female patients was
significantly higher than mortality in male patients, this difference
disappeared after adjusting for baseline characteristics.
In this study, 21% of patients with AMI in Egypt were female.
This is a substantially lower percentage than reported in a large
study conducted in developed countries throughout the world
[14], but is comparable to the percentage of patients with AMI
who were female in a study conducted in the Gulf region (21% in
Egypt vs. 32% globally vs. 19% in Gulf region) [5]. Given that
44% of individuals in the Gulf registry were expatriates [15], the
low percentage of female patients in Egypt and the Gulf prompt us
to look at broader issues of access to care and care seeking
behavior for women of this region.
Our findings of gender differences in Egyptian patients’ initial
clinical profile are congruent with findings from large national and
global studies [3,16–18]. A study using data from the Global
Registry for Acute Coronary Events (GRACE) that examined
43,393 patients (14,180 women and 29,213 men) with acute
coronary syndromes from 14 countries observed similar patterns.
In the GRACE study, women with ACS were more likely to be
older, have higher rates of hypertension, diabetes, and high
cholesterol, and have prior heart failure compared with male
patients, whereas men were more likely to smoke, have undergone
previous PCI, and present with ST-elevated EKG findings upon
admission [14]. It is interesting that gender differences in initial
clinical profile among AMI patients in Egypt are similar to the
gender differences found elsewhere, despite the younger average
age and higher prevalence of risk factors, such as diabetes mellitus
and smoking, overall in Egypt.
Consistent with other studies [19–21], we also found that female
patients with AMI experienced small but significant differences in
receipt of certain key services compared with male patients. One
recent study by Jneid and colleagues examining gender differences
in care processes among 78,254 patients with AMI in 420 US
hospitals also found small but significant differences in the
administration of aspirin within 24 hours [2]. However, Jneid
et al. also documented the underuse of other evidence-based
treatments and lower use of revascularization procedures for
women. These additional findings regarding revascularization may
not translate to Egypt, considering that resource constraints have
led to limited adoption of catheterization as the primary
reperfusion strategy in the participating hospitals. While the lack
of gender differences in in-hospital outcomes following risk
adjustment in our study is consistent with much of the literature
[2,20,22,23], the point estimate and confidence intervals in our
study cannot exclude a clinically-important difference. Other
studies have found that this risk-adjusted gender difference in
mortality persists for younger women [1,19], although age alone
was not a major attenuating factor and such an effect was not
pronounced in this study when repeated using stratified analysis.
The findings in Egypt are also comparable to findings from
other countries in the region. The Gulf Registry of Acute
Coronary Events (Gulf RACE) examined gender differences in
8,169 consecutive patients (74% men, 24% women) presenting
with acute coronary syndromes from 6 adjacent Middle Eastern
countries (Kuwait, Oman, United Arab Emirates, Yemen, and
Bahrain) [5]. The study found that women were more likely to be
older, have diabetes, hypertension, and dyslipidemia and were less
likely to be smokers. The Gulf RACE study also noted a regional
bias towards better clinical care for men, though the gender
differences were slightly larger in magnitude than our study. While
Gulf RACE did not find differences in administration of aspirin,
statins, or anticoagulants in hospital, the study did find that
women were significantly less likely to receive beta blockers (56%
vs. 63%) and certain anti-platelet therapies (2% vs. 9%).
Additionally, Gulf Race noted a significant difference in crude
mortality rates among women and men with AMI (8.1% and
3.7%, respectively). However, these numbers are smaller in
magnitude than the crude mortality rates noted in Egypt. In
contrast to the findings on in-hospital outcomes in Egypt, the
significant gender difference in in-hospital mortality in the Gulf
RACE study persisted after adjustment for potential confounders
(OR 1.76; 95% CI: 1.1 to 2.8), although the point estimate from
the Gulf RACE study lies within the confidence interval from our
fully adjusted model.
The gender differences in initial clinical profile in Egypt reflect
similar differences found throughout the world [14]. It is notable
that adjustment for this initial clinical profile results attenuated any
significant gender differences in in-hospital mortality in our study.
These differences in clinical profile may also help explain some of
the differences in clinical care. For instance, the lower rate of
administration of aspirin within the first 24 hours for female
patients may be attributed to the fact that women may often
present with atypical symptoms, and hospitals may not recognize a
myocardial infarction in women initially [24,25]. These differences
in initial clinical presentation have implications for both provider
education and sensitization to AMI in women.
Table 3. Gender differences in in-hospital mortality.
Men Women p-value* Sample size
No. deceased/Total 67/754 34/200
Mortality rate, % 8.89% 17.00%
Odds Ratio, OR (95% CI)
Unadjusted 1.00 (Ref.) 2.10 (1.54, 2.87) ,0.001 954
Adjusted for age 1.00 (Ref.) 1.66 (1.14, 2.42) 0.008 930
Adjusted for age and risk factors
b 1.00 (Ref.) 1.26 (0.84, 1.89) 0.257 901
Adjusted for age, risk factors,
b and prior cardiac history 1.00 (Ref.) 1.15 (0.74, 1.81) 0.530 889
Adjusted for age, risk factors,
b prior cardiac history, and initial clinical presentation 1.00 (Ref.) 1.18 (0.55, 2.55) 0.670 829
ap-values based on adjustment for clustering of data within hospital.
bRisk factors adjusted for include smoking status, hypertension, diabetes mellitus.
doi:10.1371/journal.pone.0025904.t003
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compared with men represents a true gender disparity in quality of
clinical care in Egypt. Nationally, Egyptian males are twice as
likely to be smokers as females (40% men v. 18% women) [26].
The dramatically lower rate of smoking cessation counseling for
women smokers in Egypt is striking, especially as smoking
exacerbates the risk of acute coronary events for women in
particular [27]. While only a minority of female patients with AMI
report smoking, because smoking is perceived as a predominantly
male activity in Egypt, cultural barriers or the risk of offending
female patients may be preventing physicians from approaching
the few women who do smoke. Further insights into the reasons for
these differences and the creation of interventions to eradicate
these differences in applying an important secondary prevention
treatment need to be pursued.
This study extends the existing evidence base on gender
differences among patients with AMI in lower-middle income
countries, where the proportion deaths stemming from cardiovas-
cular disease is projected to increase dramatically. One recent
study from a coronary events registry in China, also a lower-
middle income country, reported findings similar to ours, in terms
of gender differences in clinical presentation, bias towards women
in treatment, and lack of difference in in-hospital mortality [28].
However, data were only gathered from teaching hospitals,
reflecting a higher level of medical care than is representative of
health care delivery throughout China. The hospitals in our study
were purposefully selected to represent a diverse set of healthcare
facilities in Egypt. Additionally, one study from the lower-middle
income country of Thailand found that women were older, had
higher risk factors, and a higher risk for in-hospital complications
[29]. However, it only examined differences among patients with
ST-elevated AMI, which may introduce selection bias as our study
found that female patients had significantly higher rates non-ST-
elevated AMI compared with male patients. Finally, one of the
countries in Gulf RACE, Yemen, can be classified as lower-middle
income, but results on differences in gender were not reported
independently for this country.
Nevertheless, this study’s findings should be considered in light
of its limitations. All patients were enrolled in the registry after
admission to CCUs. While this allowed for standardization of
inclusion criteria among disparate hospitals, the registry excludes
patients with AMI who were admitted to other units or died before
admission to the hospital and presents a possibility for selection
bias. Because of a lack of consistent use of medical records across
participating hospitals, validating the data after patient discharge
was not generally possible. However, as providers were likely
biased to record compliance with clinical guidelines, the observed
differences in process measures of quality may be even greater in
usual care, suggesting that we may have provided a conservative
estimate of gender differences. Additionally, our relatively small
sample size may have limited our statistical power in multivariate
analysis due to the small number of female deaths in the final
model. Finally, the study did not consider outcomes beyond in-
hospital mortality, such a long-term survival, rehospitalization or
quality of life, important targets for future studies.
In conclusion, this study focuses attention on opportunities for
improvements in health care delivery in Egypt. Being cognizant of
the drastically different initial clinical profile of women compared
with men in Egypt can alert physicians to the greater absolute risk
of in hospital mortality for women with AMI. Additionally,
generally small but significant gender differences in guidelines-
recommended care highlight potential deficiencies in quality of
care and represent important opportunities for change. The
evidence presented in this study on gender differences in patients
with AMI can not only help improve quality of care in Egypt, but
can also guide quality improvement in other lower-middle income
countries, the areas of the world with the greatest current and
future global burden of heart disease.
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